Literature DB >> 11883903

Toxicological consequences of differential regulation of cytochrome p450 isoforms in rat brain regions by phenobarbital.

Sudarshan C Upadhya1, Shankar J Chinta, Harish V Pai, Michael R Boyd, Vijayalakshmi Ravindranath.   

Abstract

Cytochrome P4502B is an isoform of cytochrome P450 (P450) that is induced by the anticonvulsant drug phenobarbital. Here, we demonstrate the constitutive expression and predominant localization of CYP2B in neurons of rat brain. Administration of phenobarbital to rats resulted in selective induction of P450 levels in cortex and midbrain, while other regions were unaffected. Immunohistochemical localization of P4502B in brains of phenobarbital treated rats revealed localization of P4502B in neuronal cells, most predominantly the reticular neurons in midbrain. The anticancer agent 9-methoxy-N(2)-methylellipticinium acetate (MMEA) has been shown to exhibit preferential neuronal toxicity in vitro. Pretreatment of rats with phenobarbital potentiated the toxicity of intrathecally administered MMEA in vivo, as seen by the degeneration of reticular neurons. Thus, induction of P450 in selective regions of brain by phenobarbital would profoundly influence xenobiotic metabolism in these regions, especially in clinical situations where phenobarbital is coadministered with other psychoactive drugs/xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883903     DOI: 10.1006/abbi.2001.2727

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Phenobarbital increases monkey in vivo nicotine disposition and induces liver and brain CYP2B6 protein.

Authors:  Anna M Lee; Sharon Miksys; Rachel F Tyndale
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

2.  Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2008-07-30       Impact factor: 7.853

3.  Cytochrome p450 mRNA expression in the rodent brain: species-, sex-, and region-dependent differences.

Authors:  Marianna Stamou; Xianai Wu; Izabela Kania-Korwel; Hans-Joachim Lehmler; Pamela J Lein
Journal:  Drug Metab Dispos       Date:  2013-11-19       Impact factor: 3.922

4.  Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.

Authors:  Jibran Y Khokhar; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2010-11-24       Impact factor: 7.853

5.  Caffeine Protects Against Anticonvulsant-Induced Neurotoxicity in the Developing Rat Brain.

Authors:  Stefanie Endesfelder; Ulrike Weichelt; Cornelia Schiller; Marco Sifringer; Ivo Bendix; Christoph Bührer
Journal:  Neurotox Res       Date:  2017-06-22       Impact factor: 3.911

6.  Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs.

Authors:  Annalisa Nannelli; Francesco Rossignolo; Roberto Tolando; Paolo Rossato; Mario Pellegatti; Vincenzo Longo; P Giovanni Gervasi
Journal:  Mol Cell Biochem       Date:  2009-10-22       Impact factor: 3.396

Review 7.  Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.

Authors:  Guillermo Gervasini; Juan Antonio Carrillo; Julio Benitez
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells.

Authors:  Nidhi Kapoor; Aditya B Pant; Alok Dhawan; Uppendra N Dwievedi; Prahlad K Seth; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2007-07-24       Impact factor: 3.396

Review 9.  The constitutive androstane receptor and pregnane X receptor in the brain.

Authors:  Pablo Torres-Vergara; Yu Siong Ho; Francisca Espinoza; Francisco Nualart; Carlos Escudero; Jeffrey Penny
Journal:  Br J Pharmacol       Date:  2020-04-22       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.